Long-term risks of chemotherapy

Chemotherapy can generate new cancerous growths and may carry significant cardiovascular risks.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Current treatment regimes for many cancers are so successful that patients are surviving for much longer than initially envisaged. This presents a unique set of problems as the mutagenic effects of their chemotherapy can lead to the long-term development of a second malignancy, but the molecular interactions underlying these observations remain unclear. In February Cancer Cell, Asaf Hellman and colleagues from The Hebrew University, Jerusalem, Israel identify a mechanism by which some chemotherapy drugs create the conditions that can generate new cancerous growths.

Amplification of drug-selected genes in rodent cells is driven by recurrent breaks within chromosomal common fragile sites (CFSs), via the breakage-fusion-bridge (BFB) mechanism. Hellman et al. observed that the same mechanism is involved in the intrachromosomal amplification of the MET oncogene in a human gastric carcinoma. This suggested that in vivo induction of CFSs by chemotherapeutic drugs might play an important role in human oncogenesis (Cancer Cell ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Tudor Toma

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide